Experimental cancer drug NEV801 enters first human tests
Disease control
Completed
This early-phase trial tested an experimental drug called NEV801 in 78 adults with advanced solid tumors that had stopped responding to standard treatments. The drug was given by IV in increasing doses to find the safest dose and to see if it had any anti-cancer effects. The stud…
Phase: PHASE1 • Sponsor: Neovia Oncology Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC